In particular, we confirmed a partial intrinsic dysregulation of the EphB1-mediated pathway and the loss of the protective astrocyte phenotype relevant to one of the predominantly affected anatomical regions in ALS, by a transcriptomic approach combined with MS and/or immunolabelling across in vivo and in vitro model systems. The gene discussed is EPHB1; the disease is amyotrophic lateral sclerosis.